Department of the Navy December 8, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Notice of Intent To Grant Exclusive Patent License; Expression Pathology, Inc.
The Department of the Navy hereby gives notice of its intent to grant to Expression Pathology, Inc., a revocable, nonassignable, exclusive license to practice in the field of consumables for laser microdissection of human tissue samples for life science research, therapeutics and clinical diagnostic applications in the United States and certain foreign countries, the Government-owned inventions described in U.S. Patent No. 6,905,738: Generation of Viable Cell Active Biomaterial Patterns by Laser Transfer, Navy Case No. 79,702.// U.S. Patent No. 6,936,311: Generation of Biomaterial Microarrays by Laser Transfer, Navy Case No. 82,621.//U.S. Patent Application Serial No. 10/863,833: Biological Laser Printing for Tissue Microdissection via Indirect Photon-Biomaterial Interactions, Navy Case No. 96,075.// U.S. Patent Application Serial No. 10/863,850: Biological Laser Printing for Tissue Microdissection via Indirect Photon-Biomaterial Interactions, Navy Case No. 84,621 and any continuations, divisionals or re-issues thereof.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.